248
Participants
Start Date
March 1, 2019
Primary Completion Date
April 29, 2024
Study Completion Date
January 27, 2025
ARV-110
"Part A: Daily oral dosages are predetermined by cohort review committee after the initial starting dose cohort after the first 28 days of treatment~Part B: Daily oral dosage and schedule at a recommended Phase 2 dose based on data from Part A"
Clinical Trial Site, New York
Clinical Trial Site, Charlottesville
Clinical Trial Site, Fleming Island
Clinical Trial Site, Daytona Beach
Clinical Trial Site, The Villages
Clinical Trial Site, Gainesville
Clinical Trial Site, Altamonte Springs
Clinical Trial Site, Orange City
Clinical Trial Site, Tavares
Clinical Trial Site, Winter Park
Clinical Trial Site, Orlando
Clinical Trial Site, Vero Beach
Clinical Trial Site, West Palm Beach
Clinical Trial Site, Wellington
Clinical Trial Site, Brandon
Clinical Trial Site, Tampa
Clinical Trial Site, St. Petersburg
Clinical Trial Site, Clearwater
Clinical Trial Site, Largo
Clinical Trial Site, Fort Myers
Clinical Trial Site, Cape Coral
Clinical Trial Site, Port Charlotte
Clinical Trial Site, Naples
Clinical Trial Site, Bonita Springs
Clinical Trial Site, Bradenton
Clinical Trial Site, Sarasota
Clinical Trial Site, Venice
Clinical Trial Site, Lecanto
Clinical Trial Site, Ocala
Clinical Trial Site, Spring Hill
Clinical Trial Site, New Port Richey
Clinical Trial Site, Stuart
Clinical Trial Site, Dickson
Clinical Trial Site, Gallatin
Clinical Trial Site, Franklin
Clinical Trial Site, Hendersonville
Clinical Trial Site, Hermitage
Clinical Trial Site, Lebanon
Clinical Trial Site, Murfreesboro
Clinical Trial Site, Shelbyville
Clinical Trial Site, Smyrna
Clinical Trial Site, Nashville
Clinical Trial Site, Detroit
Clinical Trial Site, Chicago
Clinical Trial Site, Omaha
Clinical Trial Site, New Orleans
Clinical Trial Site, Salt Lake City
Clinical Trial Site, Las Vegas
Clinical Trial Site, Los Angeles
Clinical Trial Site, Orange
Clinical Trial Site, San Francisco
Clinical Trial Site, Portland
Clinical Trial Site, New Haven
Clinical Trial Site, Boston
Lead Sponsor
Arvinas Inc.
INDUSTRY